TCR² Therapeutics Appoints Cell & Gene Therapy Manufacturing Veteran Peter Olagunju as Chief Technical Officer

NEXT STORY
Immuneering Appoints Michael Bookman as General Counsel and Secretary
PREV STORY
Global proteomics market is expected to undergo a healthy growth during the forecast period and is projected to reach USD66.59 billion by 2026
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

イノビオ社、3件の前臨床試験で同社のDNAコード化モノクローナル抗体 (dMAb™) プラットフォームの効力をさらに実証し、2019年初旬の初回臨床試験に向けて準備を進める

ペンシルベニア州プリマス･ミーティング , Nov. 27, 2018 (GLOBE NEWSWIRE) -- イノビオ･ファーマシューティカルズ (Inovio Pharmaceuticals, Inc.、NASDAQ: INO) は本日、DNAコード化モノクローナル抗体 ...

author_avatar
NASDAQ Market News

Histogenics Corporation to Present at the 2017 Cell & Gene Meeting on the Mesa

WALTHAM, Mass., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leading ...

author_avatar
NASDAQ Market News

CrownBio erweitert gentechnisch veränderte Modellauswahl durch strategische Partnerschaft mit dem Shanghai Model Organisms Center (SMOC)

Die Partnerschaft ermöglicht Forschern den Zugriff auf Tausende genetisch veränderter MausmodelleSAN DIEGO, Aug. 15, ...

author_avatar
NASDAQ Market News